FDAFDA · Food and drugs·Recall number D-0561-2024
Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-count bottles, Rx only, Manufactured in Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-2272-34
Published June 26, 2024 · Recall initiated: June 4, 2024
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug
What to do
Voluntary: Firm initiated
Recall details
- Manufacturer
- Teva Pharmaceuticals USA, Inc
- Distributor
- Nationwide within the United States
- Lot
- Lot #: 100047634 Exp. Date 4/2025; 35449379A, Exp. Date 7/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.